Ocugen

OCGNNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$352.675 M

$1.04 +0.97%

Close of 22 Sept 2026

Revenue

$4.41M

#3313 by revenue

Earnings

-$68.0M

Loss-making

Shares outstanding

339,110,401

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#77AgenusAGEN$392.9M
#78Fennec PharmaceuticalsFENC$385.7M
#79OcugenOCGN$352.7M
#80Century TherapeuticsIPSC$342.2M
#81X4 PharmaceuticalsXFOR$340.1M

What if Ocugen were worth as much as…

Open the what-if tool →

Gold $30.2T

$89,156.72

Per share 85,728× higher

Bitcoin $1.74T

$5,135.95

Per share 4,938× higher

Nvidia $5.52T

$16,265.40

Per share 15,640× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Ocugen are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.